Bridgefront Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$389K	Buy	+40,889	New	+$318K	0.1%	323
2025 Q4	–	Sell	-23,650	Closed	-$180K	–	533
2025 Q3	$180K	Sell	23,650 -19,329	-45%	-$161K	0.05%	528
2025 Q2	$385K	Buy	+42,979	New	+$400K	0.1%	350
2024 Q4	–	Sell	-33,126	Closed	-$252K	–	584
2024 Q3	$252K	Buy	33,126 +20,212	+157%	+$154K	0.1%	385
2024 Q2	$79.8K	Buy	+12,914	New	+$71.3K	0.03%	456
2023 Q4	–	Sell	-16,323	Closed	-$116K	–	382
2023 Q3	$116K	Sell	16,323 -3,979	-20%	-$28.6K	0.08%	350
2023 Q2	$143K	Buy	+20,302	New	+$163K	0.08%	407
2021 Q2	–	Sell	-20,028	Closed	-$204K	–	613
2021 Q1	$204K	Buy	+20,028	New	+$207K	0.06%	583